Infasurf Purple Book BLA 020521

BLA number
020521
Proprietary names
Infasurf
Proper names
calfactant
Applicant
ONY Biotech Inc.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Infasurfcalfactant351(a)210MG/6ML (35MG/ML)SuspensionIntratrachealSingle-Dose VialRxLicensed1998-07-01
002Infasurfcalfactant351(a)105MG/3ML (35MG/ML)SuspensionIntratrachealSingle-Dose VialRxLicensed2002-12-12
003Infasurfcalfactant351(a)420MG/12ML (35MG/ML)SuspensionIntratrachealSingle-Dose VialDiscLicensed

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2020-09-01U001Infasurf351(a)RxONY Biotech Inc.
2020-09-01U002Infasurf351(a)RxONY Biotech Inc.
2020-05-01R001Infasurf351(a)RxONY Biotech Inc.
2020-05-01R002Infasurf351(a)RxONY Biotech Inc.
2020-05-01R003Infasurf351(a)DiscONY Biotech Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Infasurf351(a)RxLicensed1998-07-01
2020-08-01002Infasurf351(a)RxLicensed2002-12-12
2020-05-01001Infasurf351(a)RxLicensed2002-12-12
2020-05-01002Infasurf351(a)RxLicensed1998-07-01
2020-05-01003Infasurf351(a)DiscLicensed